Home › Hereditary Nonpolyposis Colorectal Cancer › Michigan
Hereditary Nonpolyposis Colorectal Cancer clinical trials in Michigan
3 studies for Hereditary Nonpolyposis Colorectal Cancer are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- University of Michigan Rogel Cancer Center, Ann Arbor
- Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit, Detroit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07811193FITting Non-invasive Tests in Lynch Syndrome Surveillance
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 20 to 80 · All sexes · Updated Apr 16, 2026 · NCT06898996The Cancer of the Pancreas Screening-5 CAPS5)Study
- University of Michigan, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT02000089From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.